NEW YORK (GenomeWeb News) – Molecular Devices today announced a global distribution agreement with Fluxion Biosciences covering its IonFlux instruments and consumables.

Molecular Devices also is providing support for all IonFlux Systems users as part of the deal, it said.

Financial and other terms of the deal were not disclosed.

South San Francisco, Calif.-based Fluxion provides tools for cellular analysis. Its portfolio includes instruments for live cell imaging and the analysis of circulating tumor cells. The Ion Flux is for automated patch clamping.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The World Health Organization calls for the public release of clinical trial results within a year of the completion of data collection.

In Science this week: measles virus nucleocapsid structure, and more.

African and US health officials work to establish an Africa-wide Centres for Disease Control and Prevention.

Nature has retracted a 2002 epigenetics paper for image manipulation.